Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
To access this article, please choose from the options below
Drs. Abe and Muto contributed equally to this work.
PII: S0301-472X(09)00138-6
doi:10.1016/j.exphem.2009.04.008
© 2009 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
